Watson Laboratories Inc recalls Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0.1 mg/0.025 mg, 0.125 mg/0.025 mg, 0.15
Recalled December 26, 2012 · FDA recall D-094-2013 · Watson Laboratories
Hazard
Impurities/Degradation Products: Out-of-specification results were obtained for a known impurities. · FDA Class III
Units
63,627 cartons
Sold at
Nationwide
Description
Impurities/Degradation Products: Out-of-specification results were obtained for a known impurities.
Product
Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0.1 mg/0.025 mg, 0.125 mg/0.025 mg, 0.15 mg/0.025 mg, 28-count tablets per dispenser (NDC 52544-959-28), packaged in 3-count Tablet Dispensers per carton (NDC 52544-959-31), Rx only Manufactured by: Watson Laboratories, Inc., Corona, CA 92880; Distributed by: Watson Pharma, Inc., Corona, CA 92880.
Manufacturer(s)
Watson Laboratories Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →